ONC Q1 2021 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q1 2021 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$606M+1063.8% YoY

Gross Profit

$573M94.6% margin

Operating Income

$70M11.6% margin

Net Income

$66M11.0% margin

EPS (Diluted)

$0.65

QoQ Revenue Growth

+505.3%

Cash Flow

Operating Cash Flow

$125M

Free Cash Flow

$74M

Stock-Based Comp.

$46M

Balance Sheet

Total Assets

$5.8B

Total Liabilities

$1.8B

Stockholders' Equity

$4.0B

Cash & Equivalents

$1.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$606M	$52M	+1063.8%
Gross Profit	$573M	$38M	+1412.0%
Operating Income	$70M	-$374M	+118.8%
Net Income	$66M	-$364M	+118.3%